Vitamin D Inhibits Ovarian Cancer Cell Line Proliferation in Combination with Celecoxib and Suppresses Cyclooxygenase-2 Expression

被引:1
|
作者
Thill, Marc [1 ]
Woeste, Alena [2 ]
Reichert, Kathrin [2 ]
Fischer, Dorothea [2 ]
Rody, Achim [2 ]
Friedrich, Michael [3 ]
Koester, Frank [2 ]
机构
[1] Agaples Markus Hosp, Dept Gynecol & Obstet, Frankfurt, Germany
[2] Med Univ Lubeck, Dept Gynecol & Obstet, D-23538 Lubeck, Germany
[3] Helios Hosp Krefeld, Dept Gynecol & Obstet, Krefeld, Germany
关键词
Vitamin D; celecoxib; cyclooxygenase-2; ovarian cancer; PROSTAGLANDIN METABOLIZING ENZYMES; PROSTATE-CANCER; D-RECEPTOR; 1,25-DIHYDROXYVITAMIN D-3; BREAST-CANCER; GROWTH-STIMULATION; COX-2; EXPRESSION; GENE-EXPRESSION; FALLOPIAN-TUBE; PHASE-II;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Vitamin D exhibits multiple anti-proliferative and pro-differentiating actions. Prostaglandin(PG)E2 is a tumor-promoting tissue hormone anabolized by cyclooxygenase-2 (COX-2). Recently, a link between the PG and vitamin D metabolism was reported. Materials and Methods: The influence of calcitriol and celecoxib on the proliferation of ovarian cancer cell lines was measured and the impact of calcitriol on the protein and mRNA expression of COX-2 was quantified by western blot and qRT-PCR, respectively. Results: After COX-2 induction with interleukin (IL)-1 beta, 10 mu M celecoxib did not significantly inhibit the proliferation of OVCAR-3 cells, whereas calcitriol showed such an effect; however, the combination of the two substances had an additive influence. After induction by IL-1 mu, calcitriol inhibited the COX-2 protein, as well as its mRNA expression significantly in OVCAR-3 and SKOV-3 cells. Conclusion: These data suggest a correlation between PG and vitamin D metabolism in their anti-tumorigenic activity in ovarian carcinomas.
引用
收藏
页码:1197 / 1203
页数:7
相关论文
共 50 条
  • [21] Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in ovarian cancer
    Fujimoto, J
    Toyoki, H
    Sakaguchi, H
    Jahan, I
    Alam, SM
    Tamaya, T
    ONCOLOGY REPORTS, 2006, 15 (01) : 21 - 25
  • [22] Effects of selective cyclooxygenase-2 inhibitors etoricoxib and celecoxib on colorectal cancer cell lines
    Rotelli, M. T.
    Rinaldi, M.
    Gelao, L.
    Bocale, D.
    Portincasa, P.
    Altomare, D. F.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 : 42 - 42
  • [23] LPA2 is critical for cyclooxygenase-2 expression in ovarian cancer cells
    Jeong, Kang Jin
    Park, Soon Young
    Seo, Jie Hye
    Kang, Jae Ku
    Park, Chang Gyo
    Lee, Hoi Young
    CLINICAL & EXPERIMENTAL METASTASIS, 2009, 26 (07) : 887 - 887
  • [24] Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma
    Erkinheimo, TL
    Sivula, A
    Lassus, H
    Heinonen, M
    Furneaux, H
    Haglund, C
    Butzow, R
    Ristimäki, A
    GYNECOLOGIC ONCOLOGY, 2005, 99 (01) : 14 - 19
  • [25] The retinoid fenretinide inhibits proliferation and downregulates cyclooxygenase-2 gene expression in human colon adenocarcinoma cell lines
    Merritt, G
    Aliprandis, ET
    Prada, F
    Rigas, B
    Kashfi, K
    CANCER LETTERS, 2001, 164 (01) : 15 - 23
  • [26] Rofecoxib therapy inhibits cyclooxygenase-2 expression and activity and reduces cell proliferation in Barrett's esophagus.
    Kaur, BS
    Iravani, M
    Khamnehei, N
    Namburu, S
    Lin, O
    Triadafilopoulos, G
    GASTROENTEROLOGY, 2002, 122 (04) : A287 - A287
  • [27] Micro ribonucleic acid (RNA)-101 inhibits cell proliferation and invasion of lung cancer by regulating cyclooxygenase-2
    Lv, Peng
    Zhang, Peng
    Li, Xin
    Chen, Yuan
    THORACIC CANCER, 2015, 6 (06) : 778 - 784
  • [28] Blockade of cyclooxygenase-2 inhibits proliferation and induces apoptosis in human pancreatic cancer cells
    Ding, XZ
    Tong, WG
    Adrian, TE
    ANTICANCER RESEARCH, 2000, 20 (04) : 2625 - 2631
  • [29] Vitamin D receptor and cyclooxygenase-2 expression in uterine leiomyoma tissues and their correlation
    Liu, Fujun
    Zhang, Xiao
    Yan, Keqin
    Liang, Jing
    Deng, Lin
    Feng, Dingqing
    Ling, Bin
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 (01) : 135 - 141
  • [30] The effects of combining docetaxel and cyclooxygenase-2 inhibitors on proliferation and apoptosis in epithelial ovarian cancer
    Munkarah, Adnan R.
    Ali-Fehmi, Rouba
    Jiang, John Z.
    Elhammady, Eslam
    Malone, John M., Jr.
    Saed, Ghassan M.
    ANTI-CANCER DRUGS, 2007, 18 (08) : 889 - 896